Vir Biotechnology Inc (VIR)

Return on assets (ROA)

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net income	US$ in thousands	-615,117	515,837	528,584	-298,665	-174,683
Total assets	US$ in thousands	1,919,060	2,802,090	1,954,270	918,761	512,071
ROA		-32.05%	18.41%	27.05%	-32.51%	-34.11%

December 31, 2023 calculation

ROA = Net income ÷ Total assets
= $-615,117K ÷ $1,919,060K
= -32.05%

Vir Biotechnology Inc's return on assets (ROA) has shown significant fluctuations over the past five years. In 2019 and 2020, the company experienced negative ROA, indicating that it generated a negative return on its assets during those years. However, in 2021 and 2022, the ROA improved substantially to 27.05% and 18.41%, respectively, suggesting a more efficient utilization of assets to generate profit.

However, the ROA sharply declined to -32.05% in 2023, signifying a reversal in the company's profitability and asset utilization. This negative ROA may be a cause for concern as it indicates that Vir Biotechnology Inc may not be effectively generating profit from its assets in the most recent fiscal year.

Overall, the fluctuating trend in ROA for Vir Biotechnology Inc highlights the importance of closely monitoring the company's asset management and profitability strategies to ensure sustainable financial performance.